Lipocine (LPCN)
NASDAQ:LPCN
US Market
Holding LPCN?
Track your performance easily

Lipocine (LPCN) Financial Statements

878 Followers

Lipocine Financial Overview

Lipocine's market cap is currently ―. The company's EPS TTM is $-1.615; its P/E ratio is -3.61; Lipocine is scheduled to report earnings on March 5, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 89.56K$ 7.62M$ -3.12M-$ 55.00K
Gross Profit$ 89.56K$ 7.62M$ -3.12M-$ 55.00K
EBIT$ -3.07M$ 3.22M$ -6.65M$ -3.55M$ -3.87M
EBITDA$ -2.84M$ 3.23M$ -6.64M$ -3.79M$ -4.12M
Net Income Common Stockholders$ -3.07M$ 3.51M$ -6.65M$ -3.55M$ 4.92M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 22.55M$ 24.63M$ 23.85M$ 25.79M$ 28.87M
Total Assets$ 23.03M$ 25.45M$ 24.75M$ 30.48M$ 34.02M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -22.55M$ -24.63M$ -23.85M$ -25.79M$ -28.87M
Total Liabilities$ 1.68M$ 1.43M$ 2.27M$ 1.83M$ 1.93M
Stockholders Equity$ 21.35M$ 24.01M$ 22.48M$ 28.66M$ 32.09M
Cash Flow-
Free Cash Flow$ -2.50M$ 2.41M$ -2.61M$ -3.31M$ -3.93M
Operating Cash Flow$ -2.50M$ 2.41M$ -2.61M$ -3.31M$ -3.93M
Investing Cash Flow$ 4.75M$ -4.09M$ 1.24M$ 3.56M$ 5.55M
Financing Cash Flow$ 217.44K$ -8.10K$ 421.08K$ -5.20K$ -6.02K
Currency in USD

Lipocine Earnings and Revenue History

Lipocine Debt to Assets

Lipocine Cash Flow

Lipocine Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis